FIGR vs NBIX · P/E 36, rev $156.4M vs P/E 45, rev $2.36B
Figure Technology Solutions, Inc. Class A Common Stock (FIGR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Figure Technology Solutions, Inc. Class A Common Stock (FIGR) is a capital markets company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FIGR revenue for 2025-09-30 was $156.4M. Net income was $89.8M. Revenue was up 54.8% from 2024-09-30 to 2025-09-30. FIGR currently screens at market cap $6.61B and trailing P/E 36.5.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
FIGR currently screens at market cap $6.61B and trailing P/E 36.5. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the FIGR and NBIX stock pages for the full models.
Not investment advice.